Publications
3 shownEfficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
ClinicalTrials.gov Identifier: NCT02494583.
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 4
- Citations
- 4,954
- Institution
- University Cancer Center Hamburg
External Links
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.